(585) 768-2513
Massachusetts-based Infraredx, a subsidiary of the major Japanese medical equipment firm Nipro, has announced that its hybrid ultrasound/infrared (IVUS+NIRS) system for imaging blocked coronary arteries is now available in Japan.
Following a limited release across a small number of Japanese hospitals earlier this year, the “Makoto” intravascular mapping system is said to help cardiologists carry out specific interventions for individual patients.
Infraredx CEO Jason Bottiglieri claimed in a company release: “IVUS+NIRS technology has the potential to dramatically change the field of interventional cardiology. Two unique modalities in one catheter provide cardiologists twice the information of other imaging catheters, helping to inform personalized treatment decisions.”
